Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma.

Published in: Journal of clinical pharmacy and therapeutics (2020)

Combination BRAF and MEK inhibition present a safe and feasible treatment strategy in unresectable BRAF V600E mutant low grade ganglioglioma.

Keyphrases